MZEI

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 6/22/2017
Contact Info
  • 350 East Michigan Avenue
  • Suite 500
  • Kalamazoo, MI 49007

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000753772
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 5122 - Drugs, proprietaries, and sundries
Incorporated In: NV, USA
Year of Inc. 1984
Employees 6 a/o Jun 21, 2017
Company Officers/Contacts
David A. Esposito CEO
Stephanie Lynn Sorensen CFO
Dr. Michael E. Shannon Medical Director, President
Company Directors
David A. Esposito Chairman
Vincent C Caponi
Stephen F Meyer
Dwayne Montgomery
Dr. Michael E. Shannon
Company Notes
  • Formerly=Madison Funding, Inc. to 3-86
Service Providers
Accounting/Auditing Firm
Tanner LLC
215 South State St.
Suite 800
Salt Lake City, UT, 84111
United States

Legal Counsel
Durham, Jones & Pinegar Law
111 East Broadway
Suite 900
Salt Lake City, UT, 84111
United States

Investor Relations Firm
Not Available
MZEI Security Details
Share Structure
Market Value1 $23,996,044 a/o Sep 22, 2017
Authorized Shares 500,000,000 a/o Jan 24, 2017
Outstanding Shares 399,934,068 a/o Aug 08, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders
Shareholders of Record 2,300 a/o Mar 22, 2017
Short Selling Data
Short Interest 30,015 (5,479%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security